Karen Prange insider trades
Open-market stock purchases and sales by Karen Prange, Director at AtriCure, Inc, from SEC Form 4 filings since Feb 28, 2013.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 5, 2026 | ATRC AtriCure, Inc | Sold | $138K |
| Jun 4, 2026 | OM Outset Medical, Inc | Bought (not open market) | — |
| May 20, 2026 | ATRC AtriCure, Inc | Sold | $86K |
| May 18, 2026 | ATRC AtriCure, Inc | Bought (not open market) | — |
| Feb 11, 2026 | EMBC Embecta Corp | Bought (not open market) | — |
| Jan 9, 2026 | OM Outset Medical, Inc | Bought (not open market) | — |
Companies traded
- ATRC AtriCure, Inc: 4 sales, last Aug 5, 2026
- OM Outset Medical, Inc: other filings, last Jun 4, 2026
- EMBC Embecta Corp: other filings, last Feb 11, 2026
- NVRO Nevro Corp: other filings, last Apr 3, 2025
- VRAY ViewRay, Inc: 3 buys, 2 sales, last Jul 21, 2023
- CMD Cantel Medical Corp: other filings, last Jun 2, 2021
- HSIC Henry Schein Inc: other filings, last Mar 2, 2018
- BSX Boston Scientific Corp: 6 sales, last Mar 8, 2016